JP2019527039A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019527039A5 JP2019527039A5 JP2018565368A JP2018565368A JP2019527039A5 JP 2019527039 A5 JP2019527039 A5 JP 2019527039A5 JP 2018565368 A JP2018565368 A JP 2018565368A JP 2018565368 A JP2018565368 A JP 2018565368A JP 2019527039 A5 JP2019527039 A5 JP 2019527039A5
- Authority
- JP
- Japan
- Prior art keywords
- ibd
- expression
- genes
- gene
- individual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1611738.4 | 2016-07-05 | ||
| GBGB1611738.4A GB201611738D0 (en) | 2016-07-05 | 2016-07-05 | Biomarkers for inflammatory bowel disease |
| PCT/IB2017/000997 WO2018007872A1 (en) | 2016-07-05 | 2017-07-05 | Biomarkers for inflammatory bowel disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020136564A Division JP2020198884A (ja) | 2016-07-05 | 2020-08-13 | 炎症性腸疾患用のバイオマーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019527039A JP2019527039A (ja) | 2019-09-26 |
| JP2019527039A5 true JP2019527039A5 (https=) | 2019-11-28 |
| JP7111630B2 JP7111630B2 (ja) | 2022-08-02 |
Family
ID=56891052
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018565368A Expired - Fee Related JP7111630B2 (ja) | 2016-07-05 | 2017-07-05 | 炎症性腸疾患用のバイオマーカー |
| JP2020136564A Pending JP2020198884A (ja) | 2016-07-05 | 2020-08-13 | 炎症性腸疾患用のバイオマーカー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020136564A Pending JP2020198884A (ja) | 2016-07-05 | 2020-08-13 | 炎症性腸疾患用のバイオマーカー |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US11041206B2 (https=) |
| EP (1) | EP3481964B1 (https=) |
| JP (2) | JP7111630B2 (https=) |
| KR (1) | KR102352847B1 (https=) |
| CN (1) | CN109477145B (https=) |
| AU (1) | AU2017293417B2 (https=) |
| CA (1) | CA3029912A1 (https=) |
| DK (1) | DK3481964T3 (https=) |
| ES (1) | ES2906192T3 (https=) |
| GB (1) | GB201611738D0 (https=) |
| HU (1) | HUE058197T2 (https=) |
| LT (1) | LT3481964T (https=) |
| PL (1) | PL3481964T3 (https=) |
| PT (1) | PT3481964T (https=) |
| WO (1) | WO2018007872A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10515408B2 (en) | 2003-08-13 | 2019-12-24 | Bgc Partners, Inc. | Systems and methods for bid/offer liquidity spread trading |
| GB201611738D0 (en) | 2016-07-05 | 2016-08-17 | Cambridge Entpr Ltd | Biomarkers for inflammatory bowel disease |
| US11978543B2 (en) | 2016-12-14 | 2024-05-07 | Astarte Medical Partners Inc. | System and methods for developing and using a microbiome-based action component |
| EP3554362A4 (en) * | 2016-12-14 | 2020-08-12 | Warren, Tracy | SYSTEM AND METHODS FOR DEVELOPING AND USING A MICROBIOME-BASED ACTION COMPONENT FOR PATIENT HEALTH |
| WO2020078993A1 (en) | 2018-10-18 | 2020-04-23 | T.J.Smith And Nephew,Limited | Tissue treatment device |
| GB201817052D0 (en) | 2018-10-19 | 2018-12-05 | Smith & Nephew | Tissue treatment device |
| CN110400603A (zh) * | 2019-07-23 | 2019-11-01 | 中国石油大学(华东) | 基于格局加权的ibd矩阵计算方法 |
| GB201912518D0 (en) | 2019-08-30 | 2019-10-16 | Cambridge Entpr Ltd | Inflammatory disease prognostics |
| GB202005867D0 (en) | 2020-04-22 | 2020-06-03 | Smith & Nephew | Tissue treatment device |
| GB202100527D0 (en) | 2021-01-15 | 2021-03-03 | Smith & Nephew | Systems and methods for managing operation of wound dressings or wound treatment devices |
| MX2023010694A (es) * | 2021-03-12 | 2023-11-23 | Janssen Biotech Inc | Métodos para predecir la respuesta al tratamiento en la colitis ulcerosa. |
| CN114517228A (zh) * | 2021-12-31 | 2022-05-20 | 青岛锐翌精准医学检验有限公司 | 炎症性肠病标志基因及其应用 |
| CN114645088B (zh) * | 2022-04-22 | 2023-12-15 | 广东省人民医院 | 克罗恩病进展风险相关评估基因集、试剂盒、应用和系统 |
| EP4606910A1 (en) * | 2024-02-21 | 2025-08-27 | Royal College of Surgeons in Ireland | Diagnostic and prognostic methods relating to ulcerative colitis |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0412301D0 (en) | 2004-06-02 | 2004-07-07 | Diagenic As | Product and method |
| US20070020660A1 (en) | 2005-06-06 | 2007-01-25 | Burczynski Michael E | Expression profiles of peripheral blood mononuclear cells for inflammatory bowel diseases |
| GB0610949D0 (en) * | 2006-06-02 | 2006-07-12 | Glaxosmithkline Biolog Sa | Method |
| EP2261367A3 (en) * | 2007-11-29 | 2011-03-23 | Genentech, Inc. | Gene expression markers for inflammatory bowel disease |
| EP2268600A4 (en) * | 2008-04-02 | 2012-03-21 | Metaproteomics Llc | SUBSTITUTED 1,3-CYCLOPENTADION-ENHANCED ENDOTHELIAL IGNITION AND ENDOTHELIAL MONOCYTE INTERACTIONS |
| KR100985090B1 (ko) * | 2008-05-23 | 2010-10-04 | 한국과학기술연구원 | 크라이센 노출 여부 확인용 바이오마커 및 이를 이용한확인 방법 |
| WO2010084312A1 (en) | 2009-01-20 | 2010-07-29 | Cambridge Enterprise Limited | Methods for predicting autoimmune disease risk |
| EP2419532A1 (en) * | 2009-04-17 | 2012-02-22 | Université Libre de Bruxelles | Methods and tools for predicting the efficiency of anthracyclines in cancer |
| EP2272977A1 (en) | 2009-07-08 | 2011-01-12 | Universite Libre De Bruxelles | Diagnostic method and kit for the detection of a lymphocytic variant of hypereosinophilic syndrome |
| WO2011127219A1 (en) | 2010-04-06 | 2011-10-13 | Caris Life Sciences Luxembourg Holdings | Circulating biomarkers for disease |
| WO2012115885A1 (en) | 2011-02-22 | 2012-08-30 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Circulating biomarkers |
| JP2014517279A (ja) | 2011-05-10 | 2014-07-17 | ネステク ソシエテ アノニム | 個別治療管理のための疾患活動性プロファイリングの方法 |
| US20130142809A1 (en) | 2011-11-23 | 2013-06-06 | Andrew A. Welcher | METHODS OF TREATMENT USING AN IFN gamma INHIBITOR |
| WO2013138497A1 (en) | 2012-03-13 | 2013-09-19 | Baylor Research Institute | Early detection of tuberculosis treatment response |
| JP2015532425A (ja) | 2012-10-05 | 2015-11-09 | ネステク ソシエテ アノニム | 粘膜治癒を予測及びモニタリングするための方法 |
| US20150315643A1 (en) | 2012-12-13 | 2015-11-05 | Baylor Research Institute | Blood transcriptional signatures of active pulmonary tuberculosis and sarcoidosis |
| WO2014145631A1 (en) * | 2013-03-15 | 2014-09-18 | The Broad Institute, Inc. | Dendritic cell response gene expression, compositions of matters and methods of use thereof |
| WO2015120382A1 (en) * | 2014-02-07 | 2015-08-13 | The Johns Hopkins University | Predicting response to epigenetic drug therapy |
| KR20220065091A (ko) | 2014-03-27 | 2022-05-19 | 제넨테크, 인크. | 염증성 장 질환의 진단 및 치료 방법 |
| US10443100B2 (en) | 2014-05-22 | 2019-10-15 | The Scripps Research Institute | Gene expression profiles associated with sub-clinical kidney transplant rejection |
| WO2016066288A1 (en) | 2014-10-28 | 2016-05-06 | Comprehensive Biomarker Center Gmbh | Mirnas as non-invasive biomarkers for inflammatory bowel disease |
| EP3262193A2 (en) * | 2015-02-26 | 2018-01-03 | The Broad Institute Inc. | T cell balance gene expression, compositions of matters and methods of use thereof |
| EP3286318A2 (en) | 2015-04-22 | 2018-02-28 | Mina Therapeutics Limited | Sarna compositions and methods of use |
| US20170003277A1 (en) * | 2015-07-01 | 2017-01-05 | Michael Hayden | Biological characterization of a glatiramer acetate related drug product using mammalian and human cells |
| GB201611738D0 (en) | 2016-07-05 | 2016-08-17 | Cambridge Entpr Ltd | Biomarkers for inflammatory bowel disease |
-
2016
- 2016-07-05 GB GBGB1611738.4A patent/GB201611738D0/en not_active Ceased
-
2017
- 2017-07-05 LT LTEPPCT/IB2017/000997T patent/LT3481964T/lt unknown
- 2017-07-05 HU HUE17768220A patent/HUE058197T2/hu unknown
- 2017-07-05 ES ES17768220T patent/ES2906192T3/es active Active
- 2017-07-05 KR KR1020197002309A patent/KR102352847B1/ko not_active Expired - Fee Related
- 2017-07-05 JP JP2018565368A patent/JP7111630B2/ja not_active Expired - Fee Related
- 2017-07-05 CA CA3029912A patent/CA3029912A1/en active Pending
- 2017-07-05 DK DK17768220.0T patent/DK3481964T3/da active
- 2017-07-05 US US15/642,252 patent/US11041206B2/en not_active Expired - Fee Related
- 2017-07-05 PL PL17768220T patent/PL3481964T3/pl unknown
- 2017-07-05 PT PT177682200T patent/PT3481964T/pt unknown
- 2017-07-05 WO PCT/IB2017/000997 patent/WO2018007872A1/en not_active Ceased
- 2017-07-05 AU AU2017293417A patent/AU2017293417B2/en not_active Ceased
- 2017-07-05 CN CN201780041664.4A patent/CN109477145B/zh not_active Expired - Fee Related
- 2017-07-05 EP EP17768220.0A patent/EP3481964B1/en active Active
- 2017-07-17 US US15/651,746 patent/US10202651B2/en active Active
-
2018
- 2018-10-12 US US16/159,114 patent/US10640829B2/en active Active
-
2020
- 2020-08-13 JP JP2020136564A patent/JP2020198884A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019527039A5 (https=) | ||
| JP6931125B2 (ja) | 標的遺伝子発現の数学的モデル化を使用する、ｊａｋ−ｓｔａｔ１／２細胞シグナル伝達経路活性の評価 | |
| JP6415712B2 (ja) | 標的遺伝子発現の数学的モデル化を用いるＴＧＦ−β細胞シグナル伝達経路活性の評価 | |
| Lin et al. | Genome-wide microarray analysis of gene expression profiling in major depression and antidepressant therapy | |
| RU2766004C1 (ru) | Способ оценки нормального состояния иммунного репертуара и его применение | |
| JP6280206B2 (ja) | 局所進行性胃癌に対する予後予測システム | |
| JP2019076096A (ja) | 目的遺伝子発現の線形結合を用いた細胞信号伝達経路活性の評価 | |
| JP2018531044A6 (ja) | 免疫レパートリーの正常性の評価方法およびその使用 | |
| JP2016525355A5 (https=) | ||
| CN109477145A (zh) | 炎症性肠病的生物标志物 | |
| JP2021518432A5 (https=) | ||
| CA2824854A1 (en) | Immunodiversity assessment method and its use | |
| WO2020151532A1 (zh) | 基于肠道微生物信息预测治疗响应性的模型 | |
| JP2016506750A5 (https=) | ||
| Chiche et al. | Current perspectives on systems immunology approaches to rheumatic diseases | |
| Ren et al. | Gene expression profiling of humans under exertional heat stress: Comparisons between persons with and without exertional heat stroke | |
| JP6974181B2 (ja) | 個体の免疫レパートリーの変化を測定するための方法 | |
| CN105506083B (zh) | Capg在制备诊断帕金森症产品中的用途 | |
| WO2019025624A1 (en) | BIOMARKERS FOR ASSESSING STATUS OF RESPONSE TO TREATMENT OF INFLAMMATORY CONDITION OR DISEASE AFFECTING THE DIGESTIVE TUBE AS AN INFLAMMATORY BOWEL DISEASE IN HUMAN PATIENTS | |
| US20170145501A1 (en) | Apparatus and methods of using of biomarkers for predicting tnf-inhibitor response | |
| Shao et al. | High-throughput sequencing reveals the diversity of TCR β chain CDR3 repertoire in patients with severe acne | |
| JP2026503318A (ja) | 便由来真核生物核酸を使用するｉｂｄ患者のための組成物及び方法 | |
| Lambrechts et al. | Gene markers in dendritic cells unravel pieces of the skin sensitization puzzle | |
| JP6612509B2 (ja) | 大腸癌の予後診断を補助する方法、記録媒体および判定装置 | |
| JP2023515952A (ja) | 免疫チェックポイント遮断治療での処置を改善するための方法 |